Myr5A peptide

• UNSPSC Description:

  Myr5A peptide is an acylated peptide composed of apolipoprotein A1 (ApoA1) analog peptide 5A peptide coupled to the saturated fatty acid myristate. Myr5A peptide self-assembled into lipid nanostructures can be used to encapsulate anthracycline Doxorubicin (HY-15142A) and Valrubicin (HY-13772) for compound release studies in vitro[1].

• Target Antigen:

  Others

• Type:

  Peptides

• Related Pathways:

  Others

• Field of Research:

  Others

• Assay Protocol:

  https://www.medchemexpress.com/myr5a-peptide.html

• Smiles:

  [{Myr}-Asp-Trp-Leu-Lys-Ala-Phe-Tyr-Asp-Lys-Val-Ala-Glu-Lys-Leu-Lys-Glu-Ala-Phe-Pro-Asp-Trp-Ala-Lys-Ala-Ala-Tyr-Asp-Lys-Ala-Ala-Glu-Lys-Ala-Lys-Glu-Ala-Ala]

• Molecular Weight:

  4428.09

• References & Citations:

  [1]Raut S, et al. Probing the assembly of HDL mimetic, drug carrying nanoparticles using intrinsic fluorescence[J]. Journal of Pharmacology and Experimental Therapeutics, 2020, 373(1): 113-121.

• Shipping Conditions:

  Room temperature

• Clinical Information:

  No Development Reported